20810 Pfizer Corporate Profile Brochure (V2) R Single Pages R sml

Pfizer South Africa

Our
Purpose
At Pfizer, we apply
science and our
global resources to
bring therapies to
people that extend
and significantly
improve their lives.
We strive to set the standard for quality, safety and value in the
discovery, development and manufacture of healthcare products.
Our global portfolio includes medicines and vaccines as well as many
of the world’s best-known consumer healthcare products.
Every day, Pfizer colleagues work across developed and emerging
markets to advance wellness, prevention, treatments and cures that
challenge the most feared diseases of our time.
Consistent with our responsibility as one of the world’s premier
innovative biopharmaceutical companies, we collaborate with
healthcare providers, governments and local communities to support
and expand access to reliable, affordable healthcare around the world.
For more than 150 years, Pfizer has worked to make a difference for
all who rely on us.
“When you have your health, you can
do whatever is a priority to you.
When you don’t, you can’t.
What I love about being part of
Pfizer is that it’s always on our mind.”
Jennifer Power
COUNTRY MANAGER
We believe that to be truly healthy, it takes more than
medication. This is why Pfizer South Africa is a healthcare
company that’s dedicated to helping South Africans live
healthier lives.
2

Our
Business
Our commercial
business is divided
into three Business
Units, each of which
broadly work in
different areas of
medicine.
These Business Units are:
Pfizer Innovative Health (PIH),
Pfizer Essential Health (PEH),
and
Pfizer Consumer Health (PCH).
Pfizer Innovative Health (PIH) is committed to discovering, developing, manufacturing
and delivering innovative products and vaccines that change the outcome of chronic
conditions and devastating diseases.
The PIH portfolio includes existing treatments and the development of new treatments in
the following therapy areas:
• Inflammation & Immunology
• Metabolic Disease & Cardiovascular Risk
• Neuroscience & Pain
• Oncology
• Rare Diseases
• Vaccines
Pfizer Essential Health (PEH) combines the history of industry leadership,
comprehensive knowledge of global healthcare markets, and a vast portfolio of trusted,
quality medicines to benefit patients around the world at virtually every stage of life.
The PEH portfolio includes medicines that treat patients for a variety of acute and
chronic conditions across many therapeutic areas, including many critical medicines and
sterile injectables:
• Anti-Infectives & Sedation
• Women’s and Men’s Health
• Cardiovascular Disease
• Neuroscience
• Pain
Pfizer Consumer Health (PCH) develops, manufactures and markets leading nonprescription
medicines, low risk medical devices (for external use) and health products
(mainly supplements).
These business units are underpinned by Enabling Functions that advance all of the company’s businesses, organisations and priorities
(such as Legal, Regulatory, HR, Business Technology, Finance and Public Affairs).
3

Our Culture and Values
Integrity
Leadership
Innovation
Respect for People
Customer Focus
Performance
Community
Quality
“I would like people to think about Pfizer
not as a building or a logo or a corporation,
but rather as a collective of individuals who
are passionate about what they come
to work to do every single day –
which is to help bring therapies to people
that significantly improve their lives.”
Collaboration
Jennifer Power
COUNTRY MANAGER
We have a culture of ownership and excellence, and empower our colleagues to achieve beyond their expectations within an open and
inclusive environment. We focus intensely on colleague development and a joint commitment to excellence. We are working to drive
transformation and contribute to socio-economic advancement via a holistic empowerment strategy aligned to the B-BBEE Act and
Codes of Good Practice.
O W N I T
We own and live our
values to deliver on
customer expectations,
and together make Pfizer
a wonderful place at
which to work.
OWN WIN NO JERKS IMPACT TRUST
the business.
in the
marketplace.
Let’s discuss
behaviors.
results. in one another.
Seize opportunities
to think differently,
take risks, try
something new.
Advocate and
drive long-term,
aligned strategies
that advance our
mission and shape
the industry.
Confront corrosive,
self-serving and
mean-spirited
behaviors:
it’s everyone’s
responsibility.
Deliver on
commitments with
speed, decisiveness,
and integrity.
Invest in candid
and constructive
debate to ensure
each other’s
success:
it’s time for
straight talk.
4

Pfizer Worldwide
9 700+ Employees
40+
Technologies / Platforms
134 Logistics Centres
150
years
175 Markets
24 500+ SKUs
200+ New R&D Collaborations
850+ Major Product Groups
Pfizer Southern Africa
64 Manufacturing Sites
9
Therapeutic / Disease Areas Being Studied
200+ Supply Partners
Cardiovascular
Gastroenterology
Haematology
Infectious
Diseases
Inflammation
Metabolic
Disease
75
Trial Centres
Oncology
20+ Clinical Trials
Biosimilars
100 Different Prescription Products
Oncology &
Inflammation
Vaccines
300+ Employees
One of SA’s Top 5 American Employers
Share Product and Disease Knowledge with 4000+ Healthcare Professionals
5

Leadership Team
Jennifer Power
COUNTRY MANAGER
Matthew Moodley
LEGAL DIRECTOR
Doreen Nel
HUMAN RESOURCES
DIRECTOR
William Themane
BUSINESS ANALYTICS
& INSIGHTS LEAD
Mahnqwa Khumalo
FINANCE DIRECTOR
Rhulani Nhlaniki
PFIZER INNOVATIVE
HEALTH CLUSTER LEAD
Dr. Tobeka Boltina
MEDICAL DIRECTOR
Bridget Barnard
LOGISTICS & SUPPLY
CHAIN MANAGER
Paul Brand
SALES DIRECTOR
Elaine Cross
BUSINESS
OPERATIONS LEAD
Marianne Zennon
COUNTRY
REGULATORY HEAD
Carl Smith
BUSINESS
TECHNOLOGY LEAD
Karen Hulett
MARKETING DIRECTOR
Johnny Moloto
DIRECTOR PUBLIC
AFFAIRS POLICY ACCESS
& COMMUNICATIONS
Atetia Visagie
GLOBAL COMMERCIAL
OPERATIONS CLUSTER
LEAD
Sue Cartwright
PFIZER CONSUMER
HEALTH COMMERCIAL
LEAD
“The most amazing
part of my job
is being part of
a team that finds
a solution to a
problem without
an obvious answer.
It’s to innovate, to
be part of improving
healthcare for
individuals, and this
team here at Pfizer
does that every
single
day.”
Jennifer Power
COUNTRY MANAGER
Larne Pearson
PRODUCT QUALITY
LEAD
History and
Milestones of
Pfizer South Africa
1849 1880s 1942 1944
Opens in Brooklyn,
New York as a fine
chemical business
Production of citric
acid puts Pfizer on
the map
Becomes a publically
traded company
World’s largest
producer of penicillin
6

Research
and Development
Research and Development is at the heart of fulfilling our purpose to help people
live healthier lives. Innovation is also the key to sustaining our growth and profitability.
As such, the quest for innovative solutions invigorates the Pfizer community globally,
and we have more than 200 new R&D collaborations active worldwide.
We are advancing next-generation science to accelerate the
development of breakthrough medicines and vaccines, and
translate technologies into therapies that significantly improve
patients’ lives.
The process is arduous and expensive: it takes an average of 12 years for a drug to reach
the market. We therefore focus our resources in disease areas with the best chance of
scientific and commercial success. Clinical studies find the answers necessary to develop
innovative new therapies, and clinical trials make it possible for participating patients to
receive state-of-the-art care from the leading experts in the field.
In South Africa alone, we run over 20 Clinical Trials at 75 Trial
Centres annually.
Scientific
Collaborations
Biovac Technology Transfer
The Pfizer-Biovac Technology Transfer is a public-private initiative to locally manufacture
a vaccine crucial for the prevention of pneumonia-related deaths, particularly in children
up to the age of five. Launched in 2015, the project entails a skills and technology
transfer from Pfizer to Biovac that will provide it with the capability to manufacture the
vaccine by 2019.
“We’re
contributing to
the knowledge
economy, we’re
contributing
to innovation,
and we are
contributing to the
man in the street
in making sure
that the right
vaccine gets to
where it needs to
get to so that he
can focus on other
aspects of life.”
Morena Makhoana
BIOVAC CEO
1951 1953 1950s 1961 1962 1967
Enters SA market
with distribution via
Petersen Ltd.
Sets up own
pharmaceutical
promotional activity
in SA
Branches into
agricultural sector
World headquarters
established in
New York
Acquires Choats Co.
and African Chemical
Corporation
Johannesburg
becomes regional HQ
for Southern Africa
7

Supply
Chain
Security
Our supplier quality management systems help ensure high quality materials
are procured for our products.
Our conveyance security standards enable our medicines to be transported safely and
help prevent illicit dugs from entering the corporate supply chain.
We enact applicable local market legislation and regulations that strengthen our
supply chain.
Our security programmes help protect our warehousing facilities and warehouses
from criminals.
Our global packaging technology programme is designed to help prevent counterfeiting
of our products.
Our global bar coding programme allows us to add authentication capability to
our products.
Our established monitoring systems help us scrutinise the marketplace for the presence
of counterfeit and unsafe product.
History and
Milestones of
Pfizer South Africa
1968 1970s 1999
Pietermaritzburg
manufacturing plant
commissioned
Further acquisitions
and mergers grow
the company
Celebrates 150th anniversary
Forbes Company of the Year
Achieves Top 10 status in the industry
8

Quality
Control
Strong Quality Culture:
An environment in which everyone in Pfizer understands and embraces their
responsibility for protecting product quality and patient safety. Quality Culture is
and has always been the “key” to enable us to provide safe and quality medicines.
Management Oversight:
A holistic, multi-faceted approach to ensure product quality and adherence to
Good Manufacturing Practice (cGMP).
Global Quality Systems:
Organised according to integrated and interconnected quality processes (such
as Governance & Internal Organisation, Product Quality Assurance & Operations,
Contractor / Supplier Management and Oversight) to ensure high and consistent
product quality.
Supplier Standards / Oversight:
Ensures high commitment to Quality and Regulations from our suppliers, so that
consistent compliance for products, processes and facilities is maintained.
Adverse Event Reporting:
Our global adverse event reporting database helps identify potential issues quickly,
and helps ensure product quality and safety.
Quality / Safety Monitoring:
Processes and procedures for timely and accurate safety monitoring of investigational
and marketed products.
Innovation:
We strive to provide the framework for quality and Environmental Health & Safety
(EHS) challenges / risks through the successful collaboration with our industry,
senior leadership and regulators.
Drive Pfizer’s transformation to contribute to the country’s socio-economic advancement
Pfizer understands the B-BBEE policy and regulatory environment in South Africa and seeks to promote and achieve the objectives
of B-BBEE by driving transformation from within its South African business. In order to do so, Pfizer believes that it should implement
a holistic B-BBEE strategy which–
• is capable of making a significant impact on the beneficiaries of such B-BBEE strategy; and
• takes into account the content of the B-BBEE Act, as well as the applicable B-BBEE codes of good practice.
2000 2002 2009
2015
Merges with Warner-Lambert
Top 5 pharma company in SA
MoU with DoH: establishes anti-fungal partnership
programme to help treatment of HIV/AIDS
Acquires Pharmacia
Corporation
Acquires Wyeth
Partners with
Biovac Institute in a
Technology Transfer
Initiative
9

Our Value
Add
to the
South
African
Economy
At Pfizer we have a proud tradition of ensuring that the communities
in which we live and work benefit from our investment and from our
partnerships with key stakeholders to expand access to treatment
and affordable healthcare. Pfizer’s corporate responsibility activities
are focused on investing the full range of our resources - people, skills,
expertise and funding - to broaden access to medicines and strengthen
healthcare delivery for underserved people around the world. Several of
Pfizer’s corporate public health partnerships have had a positive impact
on healthcare in South Africa and we have both a local and global
social responsibility focus.
Our business strategy is aligned to South Africa’s socio-economic
transformation priorities and we use the B-BBEE scorecard as the
objective measure to track the progress we are making against all the
critical elements. In this regard, our contribution to the local economy
is a journey rather than an event. Every year, we build on our previous
successes as part of our long-term commitment to the country.
Unjani Clinics
Unjani Clinics is an Enterprise Development initiative that empowers black woman
Professional Nurses to own and operate their own primary healthcare clinics in their
communities, creating permanent jobs and building sustainable businesses.
Founded on an owner-operator model, the clinics serve the “bottom of the pyramid” and
underserved markets, ensuring an affordable, quality primary healthcare service and
the supply of quality medicines to the people of South Africa. The clinics are based in
communities, ensuring that the service is delivered at the point of need. Pfizer sponsored
a clinic in Hammanskraal and has provided funding for 28 Mindray DP10 Ultrasonic
Diagnostic Imaging Systems, printers, trolleys, as well as as certified training for 28 clinics
in the network.
10

“When a global
company such as
Pfizer gets involved
in a grassroots
initiative such as
Unjani, I think
it’s important to
South Africa. It’s
not only about
empowerment
of women and
job creation, but
creating access
to much needed
healthcare
services and better
lives for all.
Antifungal Partnership Programme
Since 2000, Pfizer has been in partnership with the Department of Health, donating
treatments for two opportunistic fungal infections associated with HIV and AIDS
(cryptococcal meningitis and esophageal candidiasis). Sixteen years into the programme,
South Africa has 1 264 sites, accounting for almost 50% of all the sites globally.
In 2016 alone, the value of the programme was R200 million.
The Nelson Mandela Children’s Hospital (NMCH)
NMCH is fast realising the late Nelson Mandela’s dream of a hospital offering the children
of Southern Africa state-of-the-art healthcare. Pfizer donated R3 million towards the
hospital’s construction and the purchase of two Ultrasound Imaging Units to detect
cardiothoracic defects in babies and children.
Public Health Enhancement Fund
Pfizer is a member of the Public Health Enhancement Fund (PHEF), which is a social
compact between 23 private healthcare companies and the Ministry of Health.
The purpose of the PHEF is to contribute towards the production of medical doctors,
researchers in HIV/AIDS and TB as well as capacity building for public hospital
administrators. Pfizer participates in this programme by making annual financial
contributions based on a percentage of our earnings. There is therefore a direct correlation
between what we earn from any transaction and what we give back to society.
Isn’t it
wonderful that
you can go to
work every single
day and know
that you are
actually making
a difference.”
Lynda Toussaint
UNJANI CLINICS CEO
11

Pfizer South Africa
Working Together
for a Healthier World ®
0860 Pfizer (734937)
www.pfizer.co.za
Physical Address
85 Bute Lane
Sandton
2146
Postal Address
Pfizer Laboratories (Pty) Ltd.
PO Box 783720
Sandton
2196